Strategy and Planning

The Importance of a Commercialization Mindset

We write and speak a great deal about commercialization. It’s central to the work of our clients and, therefore, to ours as well. And so, in a recent panel, we brought together three experts from The NemetzGroup — Colleen Moore, Liz Tufo, and Tracey Sacco — to share their perspectives on the topic. Over the… Read the full article…
Posted in All Categories, Organizational Development and Culture, Strategy and Planning, Vision

Optimize Your Congress Planning

Regardless of your company or drug development stage, congress events are critical undertakings; they represent both a substantial opportunity and a significant investment of time and resources. These events provide an occasion to engage with a wide range of HCPs (including KOLs) to introduce new products, present data, gather insights, and more. Depending on your… Read the full article…
Posted in All Categories, Decision-Making and Process, Strategy and Planning

Finding Partners: Standing Out in a Field of Many

When biopharma executives or business development leaders think about developing their “partnering story,” the focus is often on the innovation. That’s understandable. These are science-based organizations, and without question, the innovation is fundamental to the work. However, paying too much attention to the science at the expense of other aspects of the opportunity can lead… Read the full article…
Posted in All Categories, Decision-Making and Process, Strategy and Planning

Gaining Participation in Clinical Trials

When it comes to patient recruitment and retention for clinical trials, the bottom line is simply this: It is important and challenging in all scenarios… the difference is in how significant the focus and effort will need to be. As this article suggests, identifying, engaging, and retaining appropriate patients for clinical trials can be extremely… Read the full article…
Posted in All Categories, Decision-Making and Process, Strategy and Planning

Reboot the “Get Organized” Ideas

Last week, The NemetzGroup team met (virtually, of course!) to share insights from 2021 and how we could make 2022 even better. We broke into small Zoom groups, each of which was given 10 minutes to brainstorm on four topics: Best tried and true tools for staying organizedNew tools we loveCoping mechanisms (e.g., dealing with… Read the full article…
Posted in All Categories, Decision-Making and Process, Strategy and Planning

Commercialization: A Mindset, Not a Function

In April of this year, our e-conversation, titled “The ‘First Hire Puzzle’ of Commercialization,” examined the topic of which commercialization support role is best, depending on an organization’s phase and size. That post generated much discussion and inspired me to dig a little deeper, specifically on New Product Planning (NPP).  In short, I discovered that, especially in… Read the full article…
Posted in All Categories, Organizational Development and Culture, Strategy and Planning

Start Too Early… Before It’s Too Late

Try this: Hold up one hand to signal “stop” while using the other hand to indicate “come forward.” I used to work with someone who mimed this all the time as a way of commenting on the mixed, often conflicting messages we sometimes receive in our industry (and lives). We often discuss this “go fast,… Read the full article…
Posted in All Categories, Decision-Making and Process, Organizational Development and Culture, Strategy and Planning

Freedom to Lead

In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies. Anyone who knows me won’t be surprised that I am an advocate for the concept, having seen so many talented people bogged down in fragmented planning processes,… Read the full article…
Posted in All Categories, Decision-Making and Process, Other, Strategy and Planning

The “First Hire Puzzle” of Commercialization

As an early-stage company continues to progress its science, raise funds for its future growth, and define its corporate strategy, there comes a point when the team begins wrestling with two crucial decisions: who to hire to commercialize its precious asset and when to do so. Embracing commercialization early as the bridge from target to patient… Read the full article…
Posted in All Categories, Decision-Making and Process, Organizational Development and Culture, Strategy and Planning

Rare Diseases — It’s All About the Patient

Among all the days of the calendar, February 29th is the rarest of them all. That’s why, back in 2008, on the 25th anniversary of the Orphan Drug ACT, EURORDIS (The European Organization for Rare Disorders) designated the last day of February as “Rare Disease Day.” Its purpose was simple: to raise awareness and drive education… Read the full article…
Posted in All Categories, Decision-Making and Process, Organizational Development and Culture, Strategy and Planning
Next Page »